Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2011-03-08
2011-03-08
Schwadron, Ron (Department: 1644)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
Reexamination Certificate
active
07902348
ABSTRACT:
An isolated polynucleotide encodes JAK-3 protein. JAK-3 protein is a protein tyrosine kinase having a molecular weight of approximately 125 kDa which has tandem non-identical catalytic domains, lacks SH2 or SH3 domains, and is expressed in NK cells and stimulated or transformed T cells, but not in resting T cells. The protein itself and antibodies to this protein are also presented. Further, methods of identifying therapeutic agents for modulating the immune system make use of the foregoing.
REFERENCES:
patent: 5124251 (1992-06-01), Lanier et al.
patent: 5262522 (1993-11-01), Gearing
patent: 5283354 (1994-02-01), Lemischka
patent: 5705625 (1998-01-01), Civin et al.
patent: 5916792 (1999-06-01), Civin et al.
patent: 6136595 (2000-10-01), Ihle et al.
patent: 94/00469 (1994-01-01), None
Asao, et al. 1994. “Interleukin 2-induced activation of JAK3: possible involvement in signal transduction for c-mycinduction and cell proliferation.”FEBS Lett. 351:201-206.
Beadling, et al. 1994. “Activation of JAL kinases and STAT proteins by interleukin-2 and interferon α, but not the T cell antigen receptor, in human T lymphocytes.”EMBO J. 13:5605-5615.
Bennett, et al. 1994. “Identification and characterization of a novel tyrosine kinase from megakaryocytes.”J. Biol. Chem269:1068-1074.
Cance, et al. 1993. “Novel protein kinases expressed in human breast cancer.”Int. J. Cancer54:571-577.
Dyrberg, et al. 1986. “Peptides as antigens.”J. Exp. Med. 164:1344-1349.
Fasciglione, et al. 1996. “Hapten-carrier interactions and their role in the production of monoclonal antibodies against hydrophobic haptens.”Hybrodoma15(1):1-9.
Gnarra, et al. 1990. “Human interleukin 2 receptor β-chain gene: chromosomal localization and identification of 5′ regulatory sequences.”PNAS USA87:3440-3444.
Hunter, T. 1993. “Cytokine Connections.”Nature366:114-116.
Johnston, et al. 1994. “Phosphorylation and activation of the Jak-3 Janus kinase in response to interleukin-2.”Nature370:151-153.
Kawamura, et al. 1994. “Molecular cloning of L-JAK, a Janus family protein-tyrosine kinase expressed in natural killer cells and activated leukocytes.”PNAS USA91:6374-6378.
Kirken, et al. 1993. “Characterization of an interleukin-2 (IL-2)-induced tyrosine phosphorylated 116-kDa protein associated with IL-2 receptor β-subunit.”J. Biol. Chem. 268:22765-22770.
Lai, et al. 1994. “Characterization and expression of human JAK3 splice variants.”Blood84 Suppl. 1, 294A.
McVicar, et al. 1994. “Molecular Cloning oflsk, a carboxyl-terminalsrckinase (csk) related gene, expressed in leukocytes.”Oncogene9:2037-2044.
Miyazaki, et al. 1994. “Funktional activation of Jak1 and Jak3 by selective association with IL-2 receptor subunits.”Science266:1045-1047.
Nakamura, et al. 1994. “Heterodimerization of the IL-2 receptor β and γ chain cytoplasmic domains is required for signalling.”Nature369:330-333.
Noguchi, et al. 1993. “Characterization of the human interleukin-2 receptor γ chain gene,”J. Biol. Chem. 268:13601-13608.
Rane, et al. 1994. “JAK3: a novel JAK kinase associated with terminal differentiation of hematopoietic cells.”Oncogene9:2415-2423.
Russell, et al. 1994. “Interaction of IL-2 receptor β chain and γcchains with JAK1 and JAK3, respectively: defective γc-JAK3 association in X-linked severe combined immunodeficiency.”Aids Res. Human Retrovir. 10:S73.
Russell, et al. 1993. “Interleukin-2 receptor γ chain: a functional component of the interleukin-4 receptor.”Science262:1880-1883.
Russell, et al. 1994. “Interaction of IL-2Rβ and γcchains with Jak1 and Jak3: implications for XSCID and XCID.”Science266:1042-1045.
Safford, et al. 1994. “JAK3, a member of the JAK family of non-receptor tyrosine kinases, is expressed in the stem/progenitor cell fraction of human bone marrow.”Blood84 Suppl. 1, 122A.
Sanchez, et al. 1994. “Multiple tyrosine protein kinases in rat hippocampal neurons: isolation of Ptk-3, a receptor expressed in proliferative zones of the developing brain.”PNAS USA91:1819-1823.
Sharon, et al. 1990. “A 100-kilodalton protein is associated with the murine interleukin 2 receptor: biochemical evidence that p100 is distinct from the α and β chains.”PNAS USA87:4869-4873.
Siliciano, et al. 1992. “itk, a T-cell-specific thyrosine kinase gene inducible by interleukin 2.”PNAS USA89:11194-11198.
Stahl, et al. 1993. “The alphas, betas, and kinases of cytokine receptor complexes.”Cell74:587-590.
Takahashi, et al. 1994. “Molecular cloning of rat JAK3, a novel member of the JAK family of protein tyrosine kinases.”FEBS Lett342:124-128.
Takebe, et al., 1988. “Srα a promoter: an efficient and versatile mammalian cDNA expression system composed of the simian virus 40 early promoter and the R-U5 segment of human T-cell leukemia virus type 1 long terminal repeat.”Mol. Cell. Biol. 8:466-472.
Vitte-Mony, et al. 1994. “Signal transduction of interleukin 2 in human natural killer cells: involvement of the p56lcktyrosine kinase.”Mol. Immunol. 31:623-632.
Withuhn, et al. 1994. “Involvement of the Jak-3 Janus kinase in signalling by interleukins 2 and 4 in lymphoid and myeloid cells.”Nature370:153-157.
Zeng, et al. 1994. “JAK3 Janus kinase is involved in interleukin 7 signal pathway.”FEBS Lett. 353:289-293.
Johnston James A.
Kawamura Masaru
Leonard Warren J.
McVicar Daniel W.
O'Shea John J.
Schwadron Ron
Swanson & Bratschun L.L.C.
The United States of America as represented by the Department of
LandOfFree
Janus family kinases and identification of immune modulators does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Janus family kinases and identification of immune modulators, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Janus family kinases and identification of immune modulators will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2748362